Close

GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treatment of COVID-19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. GM
4. SPOT
5. AMZN
6. SHW
7. AAPL
8. MINN
9. NVDA
10. IBM


Go back to GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treatment of COVID-19
(NASDAQ: VIR) Delayed: 8.13 +0.03 (0.37%)
Previous Close $8.10    52 Week High $ 
Open $8.10    52 Week Low $ 
Day High $8.29    P/E N/A 
Day Low $8.07    EPS $ 
Volume 768,972